SCHEMBL3364307

SCHEMBL3364307

CON=C(CC(N)=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.48
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
SLC6A4 P31645 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 2/20 0.44
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
ALDH1A1 P00352 1/20 0.43
DRD4 P21917 2/20 0.42
DRD2 P14416 1/20 0.42
BCAT2 O15382 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2437393 0.87 SLC6A4 (0.50) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2437392 0.87 SLC6A4 (0.50) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2432542 0.86 SLC6A4 (0.55) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2432539 0.86 SLC6A4 (0.55) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2436544 0.81 POLB (0.49) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2436547 0.81 POLB (0.49) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL20953933 0.79 SLC6A4 (0.48) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2433059 0.79 SLC6A4 (0.48) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2435068 0.79 SLC6A4 (0.48) HPGDCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2433062 0.79 SLC6A4 (0.48) HPGDCYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010011302-A1 CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI, INC. (US) 2010-01-28 WO claimed
WO-2010011302-A1 CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI, INC. (US) 2010-01-28 WO disclosed